Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

OBJECTIVE: To assess the relationship among self-reported ethnicity, metabolic control, and blood pressure during treatment of type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 2,999 newly diagnosed type 2 diabetic patients recruited to the U.K. Prospective Diabetes Study who were randomized...

Detaylı Bibliyografya
Asıl Yazarlar:	Davis, T, Cull, C, Holman, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2001

Benzer Materyaller

Ethnic differences in diabetic nephropathy - The UKPDS
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
Yazar:: Wright, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
Yazar:: Levy, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
Yazar:: Levy, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

UKPDS: what was the question? UK Prospective Diabetes Study.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
Yazar:: Retnakaran, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.
Yazar:: Colagiuri, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Yazar:: Alva, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
Yazar:: Wright, A, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
Yazar:: Price, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Horton, V, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Yazar:: Kothari, V, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Yazar:: Holman, R
Baskı/Yayın Bilgisi: (2007)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Effects of three months' diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (vol 17, pg 518, 2000)
Yazar:: Manley, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
Yazar:: Rury Holman
Baskı/Yayın Bilgisi: (2022-09-01)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
Yazar:: Wright, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)